Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
06/1999
06/15/1999CA2014465C Herpesvirus recombinant poxvirus vaccine
06/15/1999CA1340595C Method for early detection of lung cancer
06/10/1999WO1999028482A2 Single-chain recombinant complexes of hepatitis c virus ns3 protease and ns4a cofactor peptide
06/10/1999WO1999028478A1 Preparation and use of recombinant influenza a virus m2 constructs and vaccines
06/10/1999WO1999028475A2 Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
06/10/1999WO1999028456A1 Splice variants for human 5-ht4 serotonin receptor and their applications, in particular for screening
06/10/1999WO1999028445A1 Live attenuated influenza vaccine
06/10/1999WO1999028442A1 CREATION OF HETEROIMMUNITY AMONGST CTXζ: METHODS AND COMPOUNDS FOR THE CONSTRUCTION OF IMPROVED V. CHOLERAE VACCINES
06/10/1999WO1999028439A2 Erythrovirus and its applications
06/10/1999WO1999028349A2 CELLS EXPRESSING ANTI-Fc RECEPTOR BINDING COMPONENTS
06/10/1999WO1999028344A2 Synthetic peptides containing citrulline recognized by rheumatoid arthritis sera as tools for diagnosis and treatment
06/10/1999WO1999027967A1 Therapeutic agents
06/10/1999WO1999027964A1 Multivalent recombinant antibodies for treating hrv infections
06/10/1999WO1999027962A1 Use of a fibrinogen receptor-antagonist for preventing disseminated intravascular coagulation
06/10/1999WO1999027961A1 Transdermal delivery of particulate vaccine compositions
06/10/1999WO1999027960A1 Vaccine compositions for mucosal administration comprising chitosan
06/10/1999WO1999027959A1 Saponin adjuvant composition
06/10/1999WO1999027958A2 Hiv-1 tat, or derivatives thereof for prophylactic and therapeutic vaccination
06/10/1999WO1999027957A1 Vaccination and methods against multiple sclerosis using specific tcr vbeta peptides
06/10/1999WO1999027956A1 Tolerance inducing combination of at least two endogenous antigens for treatment of sms, sle, iddm, etc.
06/10/1999WO1999027954A2 Mixed lipopeptide micelles for inducing an immune response
06/10/1999WO1999027944A1 Prevention and treatment of amyloidogenic disease
06/10/1999WO1999015669A3 Clostridium toxin, and method for preparing immunogenic compositions
06/10/1999WO1999013095A3 Use of multivalent chimeric peptide-loaded, mhc/ig molecules to detect, activate or suppress antigen-specific t cell-dependent immune responses
06/10/1999WO1999010375A3 Vaccine against hpv
06/10/1999WO1999007737A3 Lsr receptor, cloning and uses
06/10/1999WO1999005175A3 Diagnosis and treatment of diseases using anti-anti-t-cell receptor vbeta anti-bodies or peptides which are recognized by said antibodies, and endocrine secretion regulatory protein i (esrp1)
06/10/1999WO1998004582A8 Isolated peptides derived from mage-2
06/10/1999DE19753383A1 Verwendung von Abciximab zur Behandlung von Mikrozirkulationsstörungen Use of abciximab for treatment of microcirculatory disorders
06/10/1999CA2313028A1 Multivalent recombinant antibodies for treating hrv infections
06/10/1999CA2312920A1 Prevention and treatment of amyloidogenic disease
06/10/1999CA2312900A1 Transdermal delivery of particulate vaccine compositions
06/10/1999CA2312824A1 Use of a fibrinogen receptor-antagonist for preventing disseminated intravascular coagulation
06/10/1999CA2312043A1 Mixed lipopeptide micelles for inducing an immune response
06/10/1999CA2311892A1 Saponin adjuvant composition
06/10/1999CA2311647A1 Hiv-1 tat, or derivatives thereof for prophylactic and therapeutic vaccination
06/10/1999CA2311574A1 Cells expressing anti-fc receptor binding components
06/10/1999CA2310718A1 Vaccine compositions for mucosal administration comprising chitosan
06/10/1999CA2310541A1 Splice variants for human 5-ht4 serotonin receptor and their applications, in particular for screening
06/10/1999CA2309534A1 Synthetic peptides containing citrulline recognized by rheumatoid arthritis sera as tools for diagnosis and treatment
06/10/1999CA2309228A1 Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
06/09/1999EP0921197A2 Human disintegrin metalloprotease related to drosophila kuz gene
06/09/1999EP0921194A2 TRAILLK-2: a member of the TNF ligand family
06/09/1999EP0920623A1 Boron neutron capture therapy using pre-targeting methods
06/09/1999EP0920518A1 Stimulus-inducible i (kappa)b kinase ikk] signalsome
06/09/1999EP0920513A2 DEFINING EPITOPES OF THE OUTER MEMBRANE PROTEIN CopB OF MORAXELLA CATARRHALIS
06/09/1999EP0920512A1 Dna molecule fragments encoding for cellular uptake of mycobacterium tuberculosis and uses thereof
06/09/1999EP0920510A1 GnRH-LEUKOTOXIN CHIMERAS
06/09/1999EP0920509A1 Polypeptides capable of forming antigen binding structures with specificity for the rhesus d antigens, the dna encoding them and the process for their preparation and use
06/09/1999EP0920505A1 Mammalian cell surface antigens; related reagents
06/09/1999EP0920502A1 Methods and means for modifying complement activation
06/09/1999EP0920449A2 Peptides
06/09/1999EP0920443A1 Activated peptides and conjugates
06/09/1999CN1218691A Method for preparing oral medicine with silkworm expressed hepatitis C antigen
06/08/1999US5910575 Monoclonal antibody which binds to (125)i-labeled derivatives of cortisol-3-carboxymethyloxime-histamine and preferentially binds to unlabeled syn isomer over unlabeled anti isomer; for competitive radioimmunoassay
06/08/1999US5910574 Human trk receptors and neurotrophic factor inhibitors
06/08/1999US5910573 Monomeric and dimeric antibody-fragment fusion proteins
06/08/1999US5910572 Response regulator peptides; for screening bactericides
06/08/1999US5910488 Plasmids suitable for gene therapy
06/08/1999US5910451 Trophinin and trophinin-assisting proteins
06/08/1999US5910430 Isolated nucleic acid encoding G-protein coupled receptor (HTADX50)
06/08/1999US5910416 Adrenomedullin
06/08/1999US5910414 Diagnosing bacterial infection by screening infected tissue using probes to identify nucleic acid sequences og bacterial enzyme
06/08/1999US5910405 HCV diagnostic agents
06/08/1999US5910404 Amino acid sequence of peptide mimetic; for screening blood and blood products; use as immunogens
06/08/1999US5910310 Genetic engineered antigenic material comprising isolated whole cell culture particles as a vaccine preventing viral diseases
06/08/1999US5910306 Transdermal delivery system for antigen
06/08/1999CA2242308A1 Novel compounds
06/08/1999CA1340587C Monoclonal antibodies and vaccine development directed to human cancer-associated antigens by immunization with animal and human mucin and with synthetic carbohydrate-carrier conjugates
06/04/1999CA2253011A1 Dna encoding neospora dihydrofolate reductase-thymidylate synthase
06/03/1999WO1999027127A1 NOVEL ribB
06/03/1999WO1999027126A1 ribG
06/03/1999WO1999027125A1 ribA
06/03/1999WO1999027109A2 EXTRACELLULAR MATRIX-BINDING PROTEINS FROM $i(STAPHYLOCOCCUS AUREUS)
06/03/1999WO1999027106A1 NOVEL guaA
06/03/1999WO1999027105A2 Chlamydia pneumoniae genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
06/03/1999WO1999027104A1 Histamine and serotonin binding molecules
06/03/1999WO1999027098A2 A-33 related antigens and their pharmacological uses
06/03/1999WO1999027080A2 Human protein kinase and kinase inhibitors
06/03/1999WO1999027074A1 Novel tig
06/03/1999WO1999027073A1 deoD
06/03/1999WO1999026980A1 Methods and reagents for the utilization of sap family member proteins, novel signal transduction regulators
06/03/1999WO1999026970A1 NOVEL pth
06/03/1999WO1999026965A1 Cyclosporine derivatives and uses thereof
06/03/1999WO1999026959A1 NOVEL recJ
06/03/1999WO1999026664A1 Recombinant mycoplasma hyopneumoniae vaccine
06/03/1999WO1999026658A1 Methods for treatment of hiv or other infections using a t cell or viral activator and anti-retroviral combination therapy
06/03/1999WO1999026656A1 Monoclonal human natural antibodies
06/03/1999WO1999026655A1 Method for inhibiting premature rupture of fetal membranes, ripening of uterine cervix and preterm labor
06/03/1999WO1999026654A1 Vaccines with an ltb adjuvant
06/03/1999WO1999026653A1 Dna vaccines against tick-borne flaviviruses
06/03/1999WO1999026651A1 ribH
06/03/1999WO1999026650A1 ribB
06/03/1999WO1999026646A1 ribA
06/03/1999WO1999026475A1 ribG
06/03/1999WO1999026463A2 Tnf ligand family gene
06/03/1999WO1999018996B1 Enterococcus antigens and vaccines
06/03/1999WO1999016466A3 Vaccine compositions and methods of enhancing vaccine efficacy
06/03/1999WO1999015656A3 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
06/03/1999WO1999014353A3 Intrabody-mediated control of immune reactions
1 ... 1528 1529 1530 1531 1532 1533 1534 1535 1536 1537 1538 1539 1540 1541 1542 1543 1544 1545 1546 1547 1548 ... 1823